vTv Therapeutics Inc (VTVT)
26.10
+0.60
(+2.35%)
USD |
NASDAQ |
May 09, 16:00
26.10
0.00 (0.00%)
After-Hours: 20:00
vTv Therapeutics Cash from Financing (TTM): 12.00M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 12.00M |
September 30, 2023 | 15.95M |
June 30, 2023 | 21.78M |
March 31, 2023 | 26.82M |
December 31, 2022 | 14.75M |
September 30, 2022 | 11.35M |
June 30, 2022 | 17.38M |
March 31, 2022 | 18.72M |
December 31, 2021 | 26.98M |
September 30, 2021 | 32.84M |
June 30, 2021 | 21.39M |
March 31, 2021 | 23.28M |
December 31, 2020 | 19.47M |
September 30, 2020 | 18.62M |
June 30, 2020 | 24.61M |
March 31, 2020 | 18.33M |
December 31, 2019 | 22.87M |
September 30, 2019 | 21.37M |
June 30, 2019 | 23.38M |
Date | Value |
---|---|
March 31, 2019 | 25.34M |
December 31, 2018 | 16.61M |
September 30, 2018 | 12.83M |
June 30, 2018 | 3.958M |
March 31, 2018 | 0.00 |
December 31, 2017 | 7.50M |
September 30, 2017 | 19.37M |
June 30, 2017 | 19.32M |
March 31, 2017 | 19.29M |
December 31, 2016 | 11.79M |
September 30, 2016 | -0.079M |
June 30, 2016 | 104.42M |
March 31, 2016 | 114.88M |
December 31, 2015 | 123.64M |
September 30, 2015 | 130.77M |
June 30, 2015 | 31.28M |
March 31, 2015 | 29.56M |
December 31, 2014 | 30.91M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
11.35M
Minimum
Sep 2022
32.84M
Maximum
Sep 2021
20.63M
Average
21.37M
Median
Sep 2019
Cash from Financing (TTM) Benchmarks
Altimmune Inc | 86.10M |
Palatin Technologies Inc | 5.553M |
Oragenics Inc | 0.2839M |
Viking Therapeutics Inc | 873.23M |
G1 Therapeutics Inc | -35.42M |